Our Medicines Manufacturing Innovation Centre opens in Glasgow, with leading digital transformation provider Atos the latest to join the partnership.
We have invested in BiologIC Technologies (BiologIC), our seventh CPI Enterprises investment to date.
The HVM Catapult joins forces with Innovation Greater Manchester and Greater Manchester Combined Authority to drive industrial transformation.
With funding from the UK Community Renewal Fund via the Northeast LEP, we’ve enabled two battery businesses to move to the region, with one investing £3m.
Jackie Waring joins our Board as Non-Executive Director, making her the fifth new Board member in 2022.
Funded by £10.65 million from the UK Government’s Vaccine Taskforce to support the development, scale-up, and manufacture of RNA vaccines and therapies.
We’ve signed a Memorandum of Understanding with The University of Manchester in a bid to boost economic growth and deliver impact.
We’ve partnered with Cellnex UK to launch a new private 5G testbed for demonstrating and commercialising HealthTech innovations.
We’ve joined the YewMaker-led Sustainable Medicines Partnership (SMP) to improve the sustainability of medicines, their manufacturing and supply chains.
Page 3 of 73
To find out more about how we can work together, please enter your details below.